PVLA Financials

Palvella Therapeutics, Inc - Financial statements & key metrics

Stock Price

$150.13

Market Cap

$1.64B

P/E Ratio

68.6

EPS

$-2.92

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-17.43M

EPS (Diluted)

$-7.83

Balance Sheet Highlights

Total Assets

$88.23M

Total Liabilities

$25.63M

Shareholders Equity

Cash & Equivalents

$83.60M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-10.84M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-301.2%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is PVLA revenue?

View PVLA's income statement for detailed revenue data.

Is PVLA profitable?

PVLA reported a loss of $17.43M in the most recent quarter.

What is PVLA market cap?

PVLA has a market capitalization of $1.64B, making it a small-cap stock.

Does PVLA have debt?

View PVLA's balance sheet for debt information.

What is PVLA cash flow?

Cash flow data is available in the full financial statements.